Detail
LncRNA Name | lncRNA-CLMAT3 |
Synonyms | CTB-113P19.1, CLMAT3, SPARC-AS1 |
Region | GRCh38_5:151676945-151724782 Sequence |
Ensembl | ENSG00000249035 |
RefSeq | NR_109873 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✘ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | colorectal cancer |
ICD-0-3 | C19.9 |
Methods | qPCR, RNAi, Western blot, Flow cytometry assay, Immunoprecipitation etc. |
Sample | cell lines (HT-29, SW480, SW620, HCT116, LOVO, and CCC-HIE-2) |
Expression Pattern | up-regulated |
Function Description | In this study, we demonstrate that lncRNA-CLMAT3 expression was significantly increased in colorectal cancer cells compared with a normal intestinal mucous cell line and that inhibition of lncRNA-CLMAT3 suppressed colorectal cancer cell proliferation in vitro. We also found that this reduced colorectal cancer cell proliferation due to lncRNA-CLMAT3 knockdown is associated with G0/G1 cell-cycle arrest induction and apoptosis enhancement. Furthermore, lncRNA-CLMAT3 knockdown enhanced Cdh1 expression and resulted in p27Kip accumulation via increased Skp2 protein ubiquitination. |
Pubmed ID | 27391344 |
Year | 2016 |
Title | Downregulated long non-coding RNA CLMAT3 promotes the proliferation of colorectal cancer cells by targeting regulators of the cell cycle pathway. |
External Links |
Links for lncRNA-CLMAT3 | GenBank HGNC lncrnadb Noncode |
Links for colorectal cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.